{
    "references": [
        {
            "bibentry": "Franzen, RG. Recent advances in the preparation of heterocycles on solid support: a review of the literature. J Comb Chem 2000; 2: 195–214. PMID: 10827923",
            "process_entry": "True",
            "doi": "10.1021/cc000002f",
            "pmid": "10827923",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Dolle, RE, Le Bourdonnec, B, Morales, GA, et al. Comprehensive survey of combinatorial library synthesis: 2005. J Comb Chem 2006; 8: 597–635. PMID: 16961395",
            "process_entry": "True",
            "doi": "10.1021/cc060095m",
            "pmid": "16961395",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "Kaushik, NK, Kaushik, N, Attri, P, et al. Biomedical importance of indoles. Molecules 2013; 18: 6620–62. PMID: 23743888",
            "process_entry": "True",
            "doi": "10.3390/molecules18066620",
            "pmid": "23743888",
            "pmcid": "PMC6270133",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "Macarron, R, Banks, MN, Bojanic, D, et al. Impact of high-throughput screening in biomedical research. Nat Rev Drug Discov 2011; 10: 188–95. PMID: 21358738",
            "process_entry": "True",
            "doi": "10.1038/nrd3368",
            "pmid": "21358738",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "Shi, F, Zeng, XN, Cao, XD, et al. Design and diversity-oriented synthesis of novel 1,4-thiazepan-3-ones fused with bioactive heterocyclic skeletons and evaluation of their antioxidant and cytotoxic activities. Bioorg Med Chem Lett 2012; 22: 743–6. PMID: 22137847",
            "process_entry": "True",
            "doi": "10.1016/j.bmcl.2011.09.081",
            "pmid": "22137847",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "Galloway, WR, Spring, DR. Is synthesis the main hurdle for the generation of diversity in compound libraries for screening? Expert Opin Drug Discov 2009; 4: 467–72. PMID: 23485081",
            "process_entry": "True",
            "doi": "10.1517/17460440902916606",
            "pmid": "23485081",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Galloway, WRJD, Isidro-Llobet, A, Spring, DR. Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. Nat Commun 2010; 1: 1. PMID: 20975674",
            "process_entry": "True",
            "doi": "10.1038/ncomms1011",
            "pmid": "20975674",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "Isidro-Llobet, A, Murillo, T, Bello, P, et al. Diversity-oriented synthesis of macrocyclic peptidomimetics. Proc Natl Acad Sci USA 2011; 108: 6793–8. PMID: 21383137",
            "process_entry": "True",
            "doi": "10.1073/pnas.1015267108",
            "pmid": "21383137",
            "pmcid": "PMC3084124",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "Galloway, WRJD, Bender, A, Welch, M, Spring, DR. The discovery of antibacterial agents using diversity-oriented synthesis. Chem Commun 2009; 18: 2446–62.",
            "process_entry": "True",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Spandl, RJ, Bender, A, Spring, DR. Diversity-oriented synthesis; a spectrum of approaches and results. Org Biomol Chem 2008; 6: 1149–58. PMID: 18362950",
            "process_entry": "True",
            "doi": "10.1039/b719372f",
            "pmid": "18362950",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Lipinski, C, Hopkins, A. Navigating chemical space for biology and medicine. Nature 2004; 432: 855–61. PMID: 15602551",
            "process_entry": "True",
            "doi": "10.1038/nature03193",
            "pmid": "15602551",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "Spring, DR. Diversity-oriented synthesis; a challenge for synthetic chemists. Org Biomol Chem 2003; 1: 3867–70. PMID: 14664374",
            "process_entry": "True",
            "doi": "10.1039/b310752n",
            "pmid": "14664374",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "Burke, MD, Berger, EM, Schreiber, SL. Generating diverse skeletons of small molecules combinatorially. Science 2003; 302: 613–8. PMID: 14576427",
            "process_entry": "True",
            "doi": "10.1126/science.1089946",
            "pmid": "14576427",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "Kennedy, JP, Williams, L, Bridges, TM, et al. Application of combinatorial chemistry science on modern drug discovery. J Comb Chem 2008; 10: 345–54. PMID: 18220367",
            "process_entry": "True",
            "doi": "10.1021/cc700187t",
            "pmid": "18220367",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Shelat, AA, Guy, RK. Scaffold composition and biological relevance of screening libraries. Nat Chem Biol 2007; 3: 442–6. PMID: 17637770",
            "process_entry": "True",
            "doi": "10.1038/nchembio0807-442",
            "pmid": "17637770",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Galloway, WRJD, Diáz-Gavilán, M, Isidro-Llobet, A, Spring, DR. Synthesis of unprecedented scaffold diversity. Angew Chem Int Ed Engl 2009; 48: 1194–6. PMID: 19137520",
            "process_entry": "True",
            "doi": "10.1002/anie.200805452",
            "pmid": "19137520",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "Sauer, WH, Schwarz, MK. Size doesn't matter: Scaffold diversity, shape diversity and biological activity of combinatorial libraries. CHIMIA Int J Chem 2003; 57: 276–83.",
            "process_entry": "True",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "Sauer, WH, Schwarz, MK. Molecular shape diversity of combinatorial libraries: a prerequisite for broad bioactivity. J Chem Inf Comput Sci 2003; 43: 987–1003. PMID: 12767158",
            "process_entry": "True",
            "doi": "10.1021/ci025599w",
            "pmid": "12767158",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Austin, ND, Sahinidis, NV, Trahan, DW. Computer-aided molecular design: An introduction and review of tools, applications, and solution techniques. Chem Eng Res Design 2016; 116: 2–26.",
            "process_entry": "True",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Floresta, G, Amata, E, Dichiara, M, et al. Identification of potentially potent heme oxygenase 1 inhibitors through 3D-QSAR coupled to scaffold-hopping analysis. ChemMedChem 2018; 13: 1336–42. PMID: 29693778",
            "process_entry": "True",
            "doi": "10.1002/cmdc.201800176",
            "pmid": "29693778",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Greish, KF, Salerno, L, Al Zahrani, R, et al. Novel structural insight into inhibitors of heme oxygenase-1 (ho-1) by new imidazole-based compounds: Biochemical and in vitro anticancer activity evaluation. Molecules 2018; 23: 1209.",
            "process_entry": "True",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "Salerno, L, Amata, E, Romeo, G, et al. Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors. Eur J Med Chem 2018; 148: 54–62. PMID: 29454190",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2018.02.007",
            "pmid": "29454190",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "Ruiz-Torres, V, Encinar, JA, Herranz-Lopez, M, et al. An updated review on marine anticancer compounds: The use of virtual screening for the discovery of small-molecule cancer drugs. Molecules 2017; 22: 1037.",
            "process_entry": "True",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "Lavecchia, A, Di Giovanni, C. Virtual screening strategies in drug discovery: a critical review. Curr Med Chem 2013; 20: 2839–60. PMID: 23651302",
            "process_entry": "True",
            "doi": "10.2174/09298673113209990001",
            "pmid": "23651302",
            "xmlid": "CIT0024"
        },
        {
            "bibentry": "Zhao, H, Lin, C, Hu, K, et al. Discovery of novel estrogen-related receptor alpha inverse agonists by virtual screening and biological evaluation. J Biomol Struct Dyn 2018; 1–8. doi: DOI: 10.1080/07391102.2018.1462736.",
            "process_entry": "True",
            "doi": "10.1080/07391102.2018.1462736.",
            "xmlid": "CIT0025"
        },
        {
            "bibentry": "Xu, X, Huang, M, Zou, X. Docking-based inverse virtual screening: Methods, applications, and challenges. Biophys Rep 2018; 4: 1–16. PMID: 29577065",
            "process_entry": "True",
            "doi": "10.1007/s41048-017-0045-8",
            "pmid": "29577065",
            "pmcid": "PMC5860130",
            "xmlid": "CIT0026"
        },
        {
            "bibentry": "Song, Y, Xue, X, Wu, X, et al. Identification of n-phenyl-2-(n-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: virtual screening, structure-based optimization, and biological evaluation. Eur J Med Chem 2016; 116: 13–26. PMID: 27043267",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2016.03.052",
            "pmid": "27043267",
            "xmlid": "CIT0027"
        },
        {
            "bibentry": "Perez, GM, Salomon, LA, Montero-Cabrera, LA, et al. Integrating sampling techniques and inverse virtual screening: Toward the discovery of artificial peptide-based receptors for ligands. Mol Divers 2016; 20: 421–38. PMID: 26553204",
            "process_entry": "True",
            "doi": "10.1007/s11030-015-9648-5",
            "pmid": "26553204",
            "xmlid": "CIT0028"
        },
        {
            "bibentry": "Lauro, G, Masullo, M, Piacente, S, et al. Inverse virtual screening allows the discovery of the biological activity of natural compounds. Bioorg Med Chem 2012; 20: 3596–602. PMID: 22537682",
            "process_entry": "True",
            "doi": "10.1016/j.bmc.2012.03.072",
            "pmid": "22537682",
            "xmlid": "CIT0029"
        },
        {
            "bibentry": "Lauro, G, Romano, A, Riccio, R, Bifulco, G. Inverse virtual screening of antitumor targets: Pilot study on a small database of natural bioactive compounds. J Nat Prod 2011; 74: 1401–7. PMID: 21542600",
            "process_entry": "True",
            "doi": "10.1021/np100935s",
            "pmid": "21542600",
            "xmlid": "CIT0030"
        },
        {
            "bibentry": "Tong, YF, Zhang, P, Chen, F, et al. Synthesis and biological evaluation of novel n-(alkoxyphenyl)-aminocarbonylbenzoic acid derivatives as ptp1b inhibitors. Chinese Chemical Letters 2010; 21: 1415–8.",
            "process_entry": "True",
            "xmlid": "CIT0031"
        },
        {
            "bibentry": "Abdel-Aziz, HA, Eldehna, WM, Fares, M, et al. Synthesis, biological evaluation and 2d-qsar study of halophenyl bis-hydrazones as antimicrobial and antitubercular agents. International Journal of Molecular Sciences 2015; 16: 8719–43. PMID: 25903147",
            "process_entry": "True",
            "doi": "10.3390/ijms16048719",
            "pmid": "25903147",
            "pmcid": "PMC4425105",
            "xmlid": "CIT0032"
        },
        {
            "bibentry": "Moldoveanu, CC, Mangalagiu, II. 4‐methyl‐and 4‐(halophenyl) pyrimidinium (4‐halobenzoyl) methylides. Correlation of structure, stability, reactivity, and biological activity. Helvetica Chimica Acta 2005; 88: 2747–56.",
            "process_entry": "True",
            "xmlid": "CIT0033"
        },
        {
            "bibentry": "Gonec, T, Zadrazilova, I, Nevin, E, et al. Synthesis and biological evaluation of n-alkoxyphenyl-3-hydroxynaphthalene-2-carboxanilides. Molecules 2015; 20: 9767–87. PMID: 26023938",
            "process_entry": "True",
            "doi": "10.3390/molecules20069767",
            "pmid": "26023938",
            "pmcid": "PMC6272341",
            "xmlid": "CIT0034"
        },
        {
            "bibentry": "Abad-Zapatero, C, Metz, JT. Ligand efficiency indices as guideposts for drug discovery. Drug Discov Today 2005; 10: 464–9. PMID: 15809192",
            "process_entry": "True",
            "doi": "10.1016/s1359-6446(05)03386-6",
            "pmid": "15809192",
            "xmlid": "CIT0035"
        },
        {
            "bibentry": "Floresta, G, Pistara, V, Amata, E, et al. Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5'-monophosphate glycosidase. Chem Biol Drug Des 2018; 91: 519–25. PMID: 28941159",
            "process_entry": "True",
            "doi": "10.1111/cbdd.13113",
            "pmid": "28941159",
            "xmlid": "CIT0036"
        },
        {
            "bibentry": "Minoo, P, Zlobec, I, Baker, K, et al. Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer. Mod Pathol 2007; 20: 331–8. PMID: 17277767",
            "process_entry": "True",
            "doi": "10.1038/modpathol.3800740",
            "pmid": "17277767",
            "xmlid": "CIT0037"
        },
        {
            "bibentry": "de Souza, PM, Lindsay, MA. Mammalian sterile20-like kinase 1 and the regulation of apoptosis. Biochem Soc Trans 2004; 32: 485–8. PMID: 15157167",
            "process_entry": "True",
            "doi": "10.1042/bst0320485",
            "pmid": "15157167",
            "xmlid": "CIT0038"
        },
        {
            "bibentry": "Han, S, Ren, Y, He, W, et al. Publisher correction: Erk-mediated phosphorylation regulates sox10 sumoylation and targets expression in mutant braf melanoma. Nat Commun 2018; 9: 1404. PMID: 29626208",
            "process_entry": "True",
            "doi": "10.1038/s41467-018-03710-1",
            "pmid": "29626208",
            "pmcid": "PMC5889394",
            "xmlid": "CIT0039"
        },
        {
            "bibentry": "Han, S, Ren, Y, He, W, et al. Erk-mediated phosphorylation regulates sox10 sumoylation and targets expression in mutant braf melanoma. Nat Commun 2018; 9: 28. PMID: 29295999",
            "process_entry": "True",
            "doi": "10.1038/s41467-017-02354-x",
            "pmid": "29295999",
            "pmcid": "PMC5750221",
            "xmlid": "CIT0040"
        },
        {
            "bibentry": "Boshuizen, J, Koopman, LA, Krijgsman, O, et al. Cooperative targeting of melanoma heterogeneity with an axl antibody-drug conjugate and braf/mek inhibitors. Nat Med 2018; 24: 203–12. PMID: 29334371",
            "process_entry": "True",
            "doi": "10.1038/nm.4472",
            "pmid": "29334371",
            "xmlid": "CIT0041"
        },
        {
            "bibentry": "Lavoie, H, Sahmi, M, Maisonneuve, P, et al. Mek drives braf activation through allosteric control of ksr proteins. Nature 2018; 554: 549–53. PMID: 29433126",
            "process_entry": "True",
            "doi": "10.1038/nature25478",
            "pmid": "29433126",
            "pmcid": "PMC6433120",
            "xmlid": "CIT0042"
        },
        {
            "bibentry": "Wang, Q, Ding, W, Ding, Y, et al. Homoharringtonine suppresses imatinib resistance via the bcl-6/p53 pathway in chronic myeloid leukemia cell lines. Oncotarget 2017; 8: 37594–604. PMID: 28410239",
            "process_entry": "True",
            "doi": "10.18632/oncotarget.16731",
            "pmid": "28410239",
            "pmcid": "PMC5514933",
            "xmlid": "CIT0043"
        },
        {
            "bibentry": "Jandl, C, Liu, SM, Canete, PF, et al. Il-21 restricts t follicular regulatory t cell proliferation through bcl-6 mediated inhibition of responsiveness to il-2. Nat Commun 2017; 8: 14647. PMID: 28303891",
            "process_entry": "True",
            "doi": "10.1038/ncomms14647",
            "pmid": "28303891",
            "pmcid": "PMC5357862",
            "xmlid": "CIT0044"
        },
        {
            "bibentry": "Qian, XL, Zhang, J, Li, PZ, et al. Dasatinib inhibits c-src phosphorylation and prevents the proliferation of triple-negative breast cancer (tnbc) cells which overexpress syndecan-binding protein (sdcbp). PLoS One 2017; 12: e0171169. PMID: 28141839",
            "process_entry": "True",
            "doi": "10.1371/journal.pone.0171169",
            "pmid": "28141839",
            "pmcid": "PMC5283743",
            "xmlid": "CIT0045"
        },
        {
            "bibentry": "Zhang, J, Wang, S, Jiang, B, et al. C-src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis. Nat Commun 2017; 8: 13732. PMID: 28054552",
            "process_entry": "True",
            "doi": "10.1038/ncomms13732",
            "pmid": "28054552",
            "pmcid": "PMC5227066",
            "xmlid": "CIT0046"
        },
        {
            "bibentry": "Pishvaian, MJ, Slack, RS, Jiang, W, et al. A phase 2 study of the parp inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer. Cancer 2018; 124: 2337–46. PMID: 29579325",
            "process_entry": "True",
            "doi": "10.1002/cncr.31309",
            "pmid": "29579325",
            "pmcid": "PMC5992024",
            "xmlid": "CIT0047"
        },
        {
            "bibentry": "Chen, X, Huan, X, Liu, Q, et al. Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious poly(adp-ribose)polymerase (parp) inhibitors. Eur J Med Chem 2018; 145: 389–403. PMID: 29335205",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2018.01.018",
            "pmid": "29335205",
            "xmlid": "CIT0048"
        },
        {
            "bibentry": "Langelier, MF, Zandarashvili, L, Aguiar, PM, et al. NAD + analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains. Nat Commun 2018; 9: 844. PMID: 29487285",
            "process_entry": "True",
            "doi": "10.1038/s41467-018-03234-8",
            "pmid": "29487285",
            "pmcid": "PMC5829251",
            "xmlid": "CIT0049"
        },
        {
            "bibentry": "Lee, JT, Li, L, Brafford, PA, et al. Plx4032, a potent inhibitor of the b-raf v600e oncogene, selectively inhibits v600e-positive melanomas. Pigment Cell Melanoma Res 2010; 23: 820–7. PMID: 20973932",
            "process_entry": "True",
            "doi": "10.1111/j.1755-148X.2010.00763.x",
            "pmid": "20973932",
            "pmcid": "PMC3623294",
            "xmlid": "CIT0050"
        },
        {
            "bibentry": "Wu, Z, Yan, M, Hu, SH, et al. Design, synthesis and biological evaluation of indole derivatives as novel inhibitors targeting b-raf kinase. Chin Chem Lett 2014; 25: 351–4.",
            "process_entry": "True",
            "xmlid": "CIT0051"
        },
        {
            "bibentry": "Melnick, A, Cerchietti, LCA, Cardenas, MG, et al. Bcl6 inhibitors as anticancer agents in Bcl6 inhibitors as anticancer agents, Google Patents. 2018.",
            "process_entry": "True",
            "xmlid": "CIT0052"
        },
        {
            "bibentry": "Olgen, S, Akaho, E, Nebioglu, D. Evaluation of indole esters as inhibitors of p60(c-src) receptor tyrosine kinase and investigation of the inhibition using receptor docking studies. Journal of Enzyme Inhibition and Medicinal Chemistry 2003; 18: 485–90. PMID: 15008512",
            "process_entry": "True",
            "doi": "10.1080/14756360310001612211\t",
            "pmid": "15008512",
            "xmlid": "CIT0053"
        },
        {
            "bibentry": "Kiliç, Z, Işgör, YG, Olgen, S. Evaluation of new indole and bromoindole derivatives as pp60(c-src) tyrosine kinase inhibitors. Chem Biol Drug Des 2009; 74: 397–404. PMID: 19691468",
            "process_entry": "True",
            "doi": "10.1111/j.1747-0285.2009.00876.x",
            "pmid": "19691468",
            "xmlid": "CIT0054"
        },
        {
            "bibentry": "Cosi, C. New inhibitors of poly(adpribose) polymerase and their potential therapeutic targets. Expert Opinion on Therapeutic Patents 2002; 12: 1047–71.",
            "process_entry": "True",
            "xmlid": "CIT0055"
        },
        {
            "bibentry": "Ren, L, Wenglowsky, S, Miknis, G, et al. Non-oxime inhibitors of b-raf(v600e) kinase. Bioorg Med Chem Lett 2011; 21: 1243–7. PMID: 21251822",
            "process_entry": "True",
            "doi": "10.1016/j.bmcl.2010.12.061",
            "pmid": "21251822",
            "xmlid": "CIT0056"
        },
        {
            "bibentry": "Johannes, JW, Almeida, L, Daly, K, et al. Discovery of az0108, an orally bioavailable phthalazinone parp inhibitor that blocks centrosome clustering. Bioorg Med Chem Lett 2015; 25: 5743–7. PMID: 26546219",
            "process_entry": "True",
            "doi": "10.1016/j.bmcl.2015.10.079",
            "pmid": "26546219",
            "xmlid": "CIT0057"
        },
        {
            "bibentry": "Thaimattam, R, Daga, PR, Banerjee, R, Iqbal, J. 3d-qsar studies on c-src kinase inhibitors and docking analyses of a potent dual kinase inhibitor of c-src and c-abl kinases. Bioorg Med Chem 2005; 13: 4704–12. PMID: 15914012",
            "process_entry": "True",
            "doi": "10.1016/j.bmc.2005.04.065",
            "pmid": "15914012",
            "xmlid": "CIT0058"
        },
        {
            "bibentry": "Olesen, SH, Zhu, J-Y, Martin, MP, Schönbrunn, E. Discovery of diverse small-molecule inhibitors of mammalian sterile20-like Kinase 3 (MST3)). ChemMedChem 2016; 11: 1137–44. PMID: 27135311",
            "process_entry": "True",
            "doi": "10.1002/cmdc.201600115",
            "pmid": "27135311",
            "xmlid": "CIT0059"
        },
        {
            "bibentry": "Sander, T, Freyss, J, von Korff, M, Rufener, C. Datawarrior: An open-source program for chemistry aware data visualization and analysis. J Chem Inf Model 2015; 55: 460–73. PMID: 25558886",
            "process_entry": "True",
            "doi": "10.1021/ci500588j",
            "pmid": "25558886",
            "xmlid": "CIT0060"
        }
    ],
    "localid": "MED-30362379",
    "doi": "10.1080/14756366.2018.1518960",
    "pmid": "10.1080/14756366.2018.1518960",
    "pmcid": "30362379",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/30362379/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 3,
                "xref_id": "CIT0001",
                "rp_string": "1–3",
                "pl_string": "1–3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,282)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 1,
                "xref_id": "",
                "pl_string": "1–3",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,282)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 2,
                "xref_id": "",
                "pl_string": "1–3",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,282)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 3,
                "xref_id": "CIT0001",
                "rp_string": "1–3",
                "pl_string": "1–3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,282)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 4,
                "xref_id": "CIT0004",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),285,233)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 5,
                "xref_id": "CIT0005",
                "rp_string": "5",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),703,260)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 9,
                "xref_id": "CIT0006",
                "rp_string": "6–8",
                "pl_string": "6–8",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,469)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 7,
                "xref_id": "",
                "pl_string": "6–8",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,469)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 8,
                "xref_id": "",
                "pl_string": "6–8",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,469)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 9,
                "xref_id": "CIT0006",
                "rp_string": "6–8",
                "pl_string": "6–8",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,469)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 10,
                "xref_id": "CIT0006",
                "rp_string": "6",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),472,212)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 11,
                "xref_id": "CIT0009",
                "rp_string": "9–12",
                "pl_string": "9–12",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),472,212)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 12,
                "xref_id": "",
                "pl_string": "9–12",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),472,212)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 13,
                "xref_id": "",
                "pl_string": "9–12",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),472,212)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 14,
                "xref_id": "",
                "pl_string": "9–12",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),472,212)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 15,
                "xref_id": "CIT0009",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),686,202)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 16,
                "xref_id": "CIT0013",
                "rp_string": "13–15",
                "pl_string": "13–15",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),686,202)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 17,
                "xref_id": "",
                "pl_string": "13–15",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),686,202)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 18,
                "xref_id": "",
                "pl_string": "13–15",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),686,202)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 19,
                "xref_id": "CIT0016",
                "rp_string": "16",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),890,294)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Scaffold diversity (i.e. variation of the nature of core scaffolds), appendage diversity (or building-block diversity, i.e. variation in structural moieties around a common scaffold), functional group diversity (i.e. variation in the functional groups present in the molecules) and stereochemical diversity (i.e. variation in the three-dimensional orientation of macromolecule-interacting residues) are the main determinants for late stage chemical diversification6–8. Indeed, it is generally recognised that the more structurally diverse a molecule is, the more likely it can interact with a particular biological macromolecule in a selective and specific manner6,7,9–12. In this context, the exploitation of scaffold diversity has a strategic role to reach amplified structural variation and explore new areas of the chemical space in biological investigations9,13–15. Moreover, it has been reported that the overall shape diversity of small-molecules is primarily dependent on the nature of the specific molecular scaffold (being the latter also intrinsically linked to functional diversity)16, with the peripheral substituents having a lower impact17,18. Therefore, there is a widespread consensus that the increase of scaffold diversity in a small-molecule library is one of the most effective means to implement its whole structural diversity6,7,9,13–15.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 20,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),890,294)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Scaffold diversity (i.e. variation of the nature of core scaffolds), appendage diversity (or building-block diversity, i.e. variation in structural moieties around a common scaffold), functional group diversity (i.e. variation in the functional groups present in the molecules) and stereochemical diversity (i.e. variation in the three-dimensional orientation of macromolecule-interacting residues) are the main determinants for late stage chemical diversification6–8. Indeed, it is generally recognised that the more structurally diverse a molecule is, the more likely it can interact with a particular biological macromolecule in a selective and specific manner6,7,9–12. In this context, the exploitation of scaffold diversity has a strategic role to reach amplified structural variation and explore new areas of the chemical space in biological investigations9,13–15. Moreover, it has been reported that the overall shape diversity of small-molecules is primarily dependent on the nature of the specific molecular scaffold (being the latter also intrinsically linked to functional diversity)16, with the peripheral substituents having a lower impact17,18. Therefore, there is a widespread consensus that the increase of scaffold diversity in a small-molecule library is one of the most effective means to implement its whole structural diversity6,7,9,13–15.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            },
            {
                "n_rp": 21,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),890,294)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Scaffold diversity (i.e. variation of the nature of core scaffolds), appendage diversity (or building-block diversity, i.e. variation in structural moieties around a common scaffold), functional group diversity (i.e. variation in the functional groups present in the molecules) and stereochemical diversity (i.e. variation in the three-dimensional orientation of macromolecule-interacting residues) are the main determinants for late stage chemical diversification6–8. Indeed, it is generally recognised that the more structurally diverse a molecule is, the more likely it can interact with a particular biological macromolecule in a selective and specific manner6,7,9–12. In this context, the exploitation of scaffold diversity has a strategic role to reach amplified structural variation and explore new areas of the chemical space in biological investigations9,13–15. Moreover, it has been reported that the overall shape diversity of small-molecules is primarily dependent on the nature of the specific molecular scaffold (being the latter also intrinsically linked to functional diversity)16, with the peripheral substituents having a lower impact17,18. Therefore, there is a widespread consensus that the increase of scaffold diversity in a small-molecule library is one of the most effective means to implement its whole structural diversity6,7,9,13–15.",
                "pl_xpath": "/article/body/sec[1]/p[2]"
            }
        ],
        [
            {
                "n_rp": 22,
                "xref_id": "CIT0006",
                "rp_string": "6",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[10]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1186,214)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0013",
                "rp_string": "13–15",
                "pl_string": "13–15",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[13]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[13]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1186,214)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 24,
                "xref_id": "",
                "pl_string": "13–15",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[13]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1186,214)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 25,
                "xref_id": "",
                "pl_string": "13–15",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[13]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1186,214)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 30,
                "xref_id": "CIT0019",
                "rp_string": "19–22",
                "pl_string": "19–22",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),225,201)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 27,
                "xref_id": "",
                "pl_string": "19–22",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),225,201)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 28,
                "xref_id": "",
                "pl_string": "19–22",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),225,201)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 29,
                "xref_id": "",
                "pl_string": "19–22",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),225,201)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 30,
                "xref_id": "CIT0019",
                "rp_string": "19–22",
                "pl_string": "19–22",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),225,201)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 31,
                "xref_id": "CIT0023",
                "rp_string": "23",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),428,262)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 36,
                "xref_id": "CIT0025",
                "rp_string": "25–28",
                "pl_string": "25–28",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),692,188)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 33,
                "xref_id": "",
                "pl_string": "25–28",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),692,188)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 34,
                "xref_id": "",
                "pl_string": "25–28",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),692,188)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 35,
                "xref_id": "",
                "pl_string": "25–28",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),692,188)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 36,
                "xref_id": "CIT0025",
                "rp_string": "25–28",
                "pl_string": "25–28",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),692,188)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 37,
                "xref_id": "CIT0018",
                "rp_string": "18",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),370,147)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 42,
                "xref_id": "CIT0031",
                "rp_string": "31–34",
                "pl_string": "31–34",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p/xref[2]",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p),1,461)",
                "containers_title": [
                    "Results and discussion",
                    "Heterocyclic small-molecule dataset"
                ]
            },
            {
                "n_rp": 39,
                "xref_id": "",
                "pl_string": "31–34",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p),1,461)",
                "containers_title": [
                    "Results and discussion",
                    "Heterocyclic small-molecule dataset"
                ]
            },
            {
                "n_rp": 40,
                "xref_id": "",
                "pl_string": "31–34",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p),1,461)",
                "containers_title": [
                    "Results and discussion",
                    "Heterocyclic small-molecule dataset"
                ]
            },
            {
                "n_rp": 41,
                "xref_id": "",
                "pl_string": "31–34",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p),1,461)",
                "containers_title": [
                    "Results and discussion",
                    "Heterocyclic small-molecule dataset"
                ]
            }
        ],
        [
            {
                "n_rp": 42,
                "xref_id": "CIT0031",
                "rp_string": "31–34",
                "pl_string": "31–34",
                "rp_xpath": "/article/body/sec[2]/sec[1]/p/xref[2]",
                "pl_xpath": "/article/body/sec[2]/sec[1]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/p),1,461)",
                "containers_title": [
                    "Results and discussion",
                    "Heterocyclic small-molecule dataset"
                ]
            }
        ],
        [
            {
                "n_rp": 43,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[1]),463,117)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            }
        ],
        [
            {
                "n_rp": 44,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[2]),356,291)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ],
                "pl_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[2]),450,11)",
                "pl_string": ".\n29\n\n,\n\n30"
            },
            {
                "n_rp": 45,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[2]),356,291)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ],
                "pl_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[2]),450,11)",
                "pl_string": ".\n29\n\n,\n\n30"
            }
        ],
        [
            {
                "n_rp": 46,
                "xref_id": "CIT0035",
                "rp_string": "35",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[4]),527,212)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            }
        ],
        [
            {
                "n_rp": 60,
                "xref_id": "CIT0037",
                "rp_string": "37–49",
                "pl_string": "37–49",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            },
            {
                "n_rp": 48,
                "xref_id": "",
                "pl_string": "37–49",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            },
            {
                "n_rp": 49,
                "xref_id": "",
                "pl_string": "37–49",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            },
            {
                "n_rp": 50,
                "xref_id": "",
                "pl_string": "37–49",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            },
            {
                "n_rp": 51,
                "xref_id": "",
                "pl_string": "37–49",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            },
            {
                "n_rp": 52,
                "xref_id": "",
                "pl_string": "37–49",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            },
            {
                "n_rp": 53,
                "xref_id": "",
                "pl_string": "37–49",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            },
            {
                "n_rp": 54,
                "xref_id": "",
                "pl_string": "37–49",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            },
            {
                "n_rp": 55,
                "xref_id": "",
                "pl_string": "37–49",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            },
            {
                "n_rp": 56,
                "xref_id": "",
                "pl_string": "37–49",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            },
            {
                "n_rp": 57,
                "xref_id": "",
                "pl_string": "37–49",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            },
            {
                "n_rp": 58,
                "xref_id": "",
                "pl_string": "37–49",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            },
            {
                "n_rp": 59,
                "xref_id": "",
                "pl_string": "37–49",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            }
        ],
        [
            {
                "n_rp": 60,
                "xref_id": "CIT0037",
                "rp_string": "37–49",
                "pl_string": "37–49",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),1,183)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ]
            }
        ],
        [
            {
                "n_rp": 61,
                "xref_id": "CIT0050",
                "rp_string": "50",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),425,309)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ],
                "pl_string": "As previously mentioned, the proteins analysed in this study play critical roles in tumour events and new binders are regarded as the potential agents for anti-cancer therapies37–49. Therefore, we examined literature records in order to cross-validate our method. Noteworthy, analogues based on the same core scaffolds have already demonstrated a good profile as inhibitors of the cellular targets analysed in this study. For instance, it has been reported that indole-based compounds are inhibitors of serine/threonine-protein kinase B-raf (BRAF)50,51, B-cell lymphoma 6 (BCL-6)52, proto-oncogene tyrosine-protein kinase Src (c-Src)53,54 and poly (ADP-ribose) polymerase (PARP)55, in clear agreement with our model. Similarly, indazole-based derivatives have been reported as inhibitors of BRAF56, phthalazinone core is present in inhibitors of PARP57, as well as quinoline scaffold is common in molecules acting as c-Src58 and mammalian sterile20-like protein kinase 3 (MST3) inhibitors59. These evidences validate our iVS method in order to enable the identification of suitable targets for a particular molecular library, foreseeing successful biological investigation.",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]"
            },
            {
                "n_rp": 62,
                "xref_id": "CIT0051",
                "rp_string": "51",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),425,309)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ],
                "pl_string": "As previously mentioned, the proteins analysed in this study play critical roles in tumour events and new binders are regarded as the potential agents for anti-cancer therapies37–49. Therefore, we examined literature records in order to cross-validate our method. Noteworthy, analogues based on the same core scaffolds have already demonstrated a good profile as inhibitors of the cellular targets analysed in this study. For instance, it has been reported that indole-based compounds are inhibitors of serine/threonine-protein kinase B-raf (BRAF)50,51, B-cell lymphoma 6 (BCL-6)52, proto-oncogene tyrosine-protein kinase Src (c-Src)53,54 and poly (ADP-ribose) polymerase (PARP)55, in clear agreement with our model. Similarly, indazole-based derivatives have been reported as inhibitors of BRAF56, phthalazinone core is present in inhibitors of PARP57, as well as quinoline scaffold is common in molecules acting as c-Src58 and mammalian sterile20-like protein kinase 3 (MST3) inhibitors59. These evidences validate our iVS method in order to enable the identification of suitable targets for a particular molecular library, foreseeing successful biological investigation.",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]"
            },
            {
                "n_rp": 63,
                "xref_id": "CIT0052",
                "rp_string": "52",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),425,309)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ],
                "pl_string": "As previously mentioned, the proteins analysed in this study play critical roles in tumour events and new binders are regarded as the potential agents for anti-cancer therapies37–49. Therefore, we examined literature records in order to cross-validate our method. Noteworthy, analogues based on the same core scaffolds have already demonstrated a good profile as inhibitors of the cellular targets analysed in this study. For instance, it has been reported that indole-based compounds are inhibitors of serine/threonine-protein kinase B-raf (BRAF)50,51, B-cell lymphoma 6 (BCL-6)52, proto-oncogene tyrosine-protein kinase Src (c-Src)53,54 and poly (ADP-ribose) polymerase (PARP)55, in clear agreement with our model. Similarly, indazole-based derivatives have been reported as inhibitors of BRAF56, phthalazinone core is present in inhibitors of PARP57, as well as quinoline scaffold is common in molecules acting as c-Src58 and mammalian sterile20-like protein kinase 3 (MST3) inhibitors59. These evidences validate our iVS method in order to enable the identification of suitable targets for a particular molecular library, foreseeing successful biological investigation.",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]"
            },
            {
                "n_rp": 64,
                "xref_id": "CIT0053",
                "rp_string": "53",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),425,309)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ],
                "pl_string": "As previously mentioned, the proteins analysed in this study play critical roles in tumour events and new binders are regarded as the potential agents for anti-cancer therapies37–49. Therefore, we examined literature records in order to cross-validate our method. Noteworthy, analogues based on the same core scaffolds have already demonstrated a good profile as inhibitors of the cellular targets analysed in this study. For instance, it has been reported that indole-based compounds are inhibitors of serine/threonine-protein kinase B-raf (BRAF)50,51, B-cell lymphoma 6 (BCL-6)52, proto-oncogene tyrosine-protein kinase Src (c-Src)53,54 and poly (ADP-ribose) polymerase (PARP)55, in clear agreement with our model. Similarly, indazole-based derivatives have been reported as inhibitors of BRAF56, phthalazinone core is present in inhibitors of PARP57, as well as quinoline scaffold is common in molecules acting as c-Src58 and mammalian sterile20-like protein kinase 3 (MST3) inhibitors59. These evidences validate our iVS method in order to enable the identification of suitable targets for a particular molecular library, foreseeing successful biological investigation.",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]"
            },
            {
                "n_rp": 65,
                "xref_id": "CIT0054",
                "rp_string": "54",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),425,309)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ],
                "pl_string": "As previously mentioned, the proteins analysed in this study play critical roles in tumour events and new binders are regarded as the potential agents for anti-cancer therapies37–49. Therefore, we examined literature records in order to cross-validate our method. Noteworthy, analogues based on the same core scaffolds have already demonstrated a good profile as inhibitors of the cellular targets analysed in this study. For instance, it has been reported that indole-based compounds are inhibitors of serine/threonine-protein kinase B-raf (BRAF)50,51, B-cell lymphoma 6 (BCL-6)52, proto-oncogene tyrosine-protein kinase Src (c-Src)53,54 and poly (ADP-ribose) polymerase (PARP)55, in clear agreement with our model. Similarly, indazole-based derivatives have been reported as inhibitors of BRAF56, phthalazinone core is present in inhibitors of PARP57, as well as quinoline scaffold is common in molecules acting as c-Src58 and mammalian sterile20-like protein kinase 3 (MST3) inhibitors59. These evidences validate our iVS method in order to enable the identification of suitable targets for a particular molecular library, foreseeing successful biological investigation.",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]"
            },
            {
                "n_rp": 66,
                "xref_id": "CIT0055",
                "rp_string": "55",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),425,309)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ],
                "pl_string": "As previously mentioned, the proteins analysed in this study play critical roles in tumour events and new binders are regarded as the potential agents for anti-cancer therapies37–49. Therefore, we examined literature records in order to cross-validate our method. Noteworthy, analogues based on the same core scaffolds have already demonstrated a good profile as inhibitors of the cellular targets analysed in this study. For instance, it has been reported that indole-based compounds are inhibitors of serine/threonine-protein kinase B-raf (BRAF)50,51, B-cell lymphoma 6 (BCL-6)52, proto-oncogene tyrosine-protein kinase Src (c-Src)53,54 and poly (ADP-ribose) polymerase (PARP)55, in clear agreement with our model. Similarly, indazole-based derivatives have been reported as inhibitors of BRAF56, phthalazinone core is present in inhibitors of PARP57, as well as quinoline scaffold is common in molecules acting as c-Src58 and mammalian sterile20-like protein kinase 3 (MST3) inhibitors59. These evidences validate our iVS method in order to enable the identification of suitable targets for a particular molecular library, foreseeing successful biological investigation.",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]"
            }
        ],
        [
            {
                "n_rp": 67,
                "xref_id": "CIT0056",
                "rp_string": "56",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),736,281)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ],
                "pl_string": "As previously mentioned, the proteins analysed in this study play critical roles in tumour events and new binders are regarded as the potential agents for anti-cancer therapies37–49. Therefore, we examined literature records in order to cross-validate our method. Noteworthy, analogues based on the same core scaffolds have already demonstrated a good profile as inhibitors of the cellular targets analysed in this study. For instance, it has been reported that indole-based compounds are inhibitors of serine/threonine-protein kinase B-raf (BRAF)50,51, B-cell lymphoma 6 (BCL-6)52, proto-oncogene tyrosine-protein kinase Src (c-Src)53,54 and poly (ADP-ribose) polymerase (PARP)55, in clear agreement with our model. Similarly, indazole-based derivatives have been reported as inhibitors of BRAF56, phthalazinone core is present in inhibitors of PARP57, as well as quinoline scaffold is common in molecules acting as c-Src58 and mammalian sterile20-like protein kinase 3 (MST3) inhibitors59. These evidences validate our iVS method in order to enable the identification of suitable targets for a particular molecular library, foreseeing successful biological investigation.",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]"
            },
            {
                "n_rp": 68,
                "xref_id": "CIT0057",
                "rp_string": "57",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),736,281)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ],
                "pl_string": "As previously mentioned, the proteins analysed in this study play critical roles in tumour events and new binders are regarded as the potential agents for anti-cancer therapies37–49. Therefore, we examined literature records in order to cross-validate our method. Noteworthy, analogues based on the same core scaffolds have already demonstrated a good profile as inhibitors of the cellular targets analysed in this study. For instance, it has been reported that indole-based compounds are inhibitors of serine/threonine-protein kinase B-raf (BRAF)50,51, B-cell lymphoma 6 (BCL-6)52, proto-oncogene tyrosine-protein kinase Src (c-Src)53,54 and poly (ADP-ribose) polymerase (PARP)55, in clear agreement with our model. Similarly, indazole-based derivatives have been reported as inhibitors of BRAF56, phthalazinone core is present in inhibitors of PARP57, as well as quinoline scaffold is common in molecules acting as c-Src58 and mammalian sterile20-like protein kinase 3 (MST3) inhibitors59. These evidences validate our iVS method in order to enable the identification of suitable targets for a particular molecular library, foreseeing successful biological investigation.",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]"
            },
            {
                "n_rp": 69,
                "xref_id": "CIT0058",
                "rp_string": "58",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[10]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),736,281)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ],
                "pl_string": "As previously mentioned, the proteins analysed in this study play critical roles in tumour events and new binders are regarded as the potential agents for anti-cancer therapies37–49. Therefore, we examined literature records in order to cross-validate our method. Noteworthy, analogues based on the same core scaffolds have already demonstrated a good profile as inhibitors of the cellular targets analysed in this study. For instance, it has been reported that indole-based compounds are inhibitors of serine/threonine-protein kinase B-raf (BRAF)50,51, B-cell lymphoma 6 (BCL-6)52, proto-oncogene tyrosine-protein kinase Src (c-Src)53,54 and poly (ADP-ribose) polymerase (PARP)55, in clear agreement with our model. Similarly, indazole-based derivatives have been reported as inhibitors of BRAF56, phthalazinone core is present in inhibitors of PARP57, as well as quinoline scaffold is common in molecules acting as c-Src58 and mammalian sterile20-like protein kinase 3 (MST3) inhibitors59. These evidences validate our iVS method in order to enable the identification of suitable targets for a particular molecular library, foreseeing successful biological investigation.",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]"
            },
            {
                "n_rp": 70,
                "xref_id": "CIT0059",
                "rp_string": "59",
                "rp_xpath": "/article/body/sec[2]/sec[2]/p[5]/xref[11]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/p[5]),736,281)",
                "containers_title": [
                    "Results and discussion",
                    "Molecular modelling"
                ],
                "pl_string": "As previously mentioned, the proteins analysed in this study play critical roles in tumour events and new binders are regarded as the potential agents for anti-cancer therapies37–49. Therefore, we examined literature records in order to cross-validate our method. Noteworthy, analogues based on the same core scaffolds have already demonstrated a good profile as inhibitors of the cellular targets analysed in this study. For instance, it has been reported that indole-based compounds are inhibitors of serine/threonine-protein kinase B-raf (BRAF)50,51, B-cell lymphoma 6 (BCL-6)52, proto-oncogene tyrosine-protein kinase Src (c-Src)53,54 and poly (ADP-ribose) polymerase (PARP)55, in clear agreement with our model. Similarly, indazole-based derivatives have been reported as inhibitors of BRAF56, phthalazinone core is present in inhibitors of PARP57, as well as quinoline scaffold is common in molecules acting as c-Src58 and mammalian sterile20-like protein kinase 3 (MST3) inhibitors59. These evidences validate our iVS method in order to enable the identification of suitable targets for a particular molecular library, foreseeing successful biological investigation.",
                "pl_xpath": "/article/body/sec[2]/sec[2]/p[5]"
            }
        ],
        [
            {
                "n_rp": 71,
                "xref_id": "CIT0060",
                "rp_string": "60",
                "rp_xpath": "/article/body/sec[2]/sec[3]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/p),178,202)",
                "containers_title": [
                    "Results and discussion",
                    "Drug score and ADME assessment"
                ]
            }
        ]
    ]
}